background: technetium-99m radioisotope is the backbone of any nuclear medicine institute. this radioisotope is acquired by the elution of molybdenum-99/technetium-99m generator which emits 141 kev gamma ray and having 6.04 hour half-life. occasionally the contents of molybdenum-99 may mix up with elute, which may affect image quality and patients may receive higher doses than recommended. this...

Synthesis of molybdenum(vi) dioxido complexes 1-3, coordinated by one or two functionalized iminophenolate ligands HL1 or HL2, bearing a donor atom side chain or a phenyl substituent, respectively, allowed for systematic investigation of the oxygen atom transfer (OAT) reactivity of such complexes towards phosphanes. Depending on stoichiometry and employed phosphane (PMe3 or PPh3), different mol...

A ll transition metals are highly toxic to life at low levels, but at the same time some, such as manganese, iron, cobalt, nickel, copper, zinc and molybdenum, are essential micronutrients needed to catalyse key enzymatic reactions. To survive, living organisms have had to evolve mechanisms that either remove such metals from their bodies or detoxify and make use of them metabolically. Many of ...

The preparation and characterization of new model complexes for the molybdenum cofactor are reported. The new models are distinctive for the inclusion of pterin-substituted dithiolene chelates and have the formulation Tp(*)MoX(pterin-R-dithiolene) (Tp(*)=tris(3,5,-dimethylpyrazolyl)borate), X=O, S, R=aryl. Syntheses of Mo(4+) and (5+) complexes of two pterin-dithiolene derivatives as both oxo a...

A 1,10-phenanthroline (phen) chelated molybdenum(VI) citrate, [(MoO2)2O(H2cit)(phen)(H2O)2] x H2O (1) (H4cit = citric acid), is isolated from the reaction of citric acid, ammonium molybdate and phen in acidic media (pH 0.5-1.0). A citrato oxomolybdenum(V) complex, [(MoO)2O(H2cit)2(bpy)2] x 4H2O (2), is synthesized by the reduction of citrato molybdate with hydrazine hydrochloride in the presenc...